ATE190484T1 - Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen - Google Patents

Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen

Info

Publication number
ATE190484T1
ATE190484T1 AT93900295T AT93900295T ATE190484T1 AT E190484 T1 ATE190484 T1 AT E190484T1 AT 93900295 T AT93900295 T AT 93900295T AT 93900295 T AT93900295 T AT 93900295T AT E190484 T1 ATE190484 T1 AT E190484T1
Authority
AT
Austria
Prior art keywords
treatment
pct
infections caused
babesia
medicinal products
Prior art date
Application number
AT93900295T
Other languages
English (en)
Inventor
Winston Edward Gutteridge
Alan Thomas Hudson
Victoria Susan Latter
Mary Pudney
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE190484T1 publication Critical patent/ATE190484T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
AT93900295T 1991-12-18 1992-12-17 Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen ATE190484T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919126874A GB9126874D0 (en) 1991-12-18 1991-12-18 Medicaments
PCT/GB1992/002344 WO1993011756A1 (en) 1991-12-18 1992-12-17 Medicament for treatment of protozoal infections

Publications (1)

Publication Number Publication Date
ATE190484T1 true ATE190484T1 (de) 2000-04-15

Family

ID=10706474

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93900295T ATE190484T1 (de) 1991-12-18 1992-12-17 Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen

Country Status (7)

Country Link
US (1) US5561164A (de)
EP (1) EP0572615B1 (de)
AT (1) ATE190484T1 (de)
DE (1) DE69230790T2 (de)
ES (1) ES2144452T3 (de)
GB (1) GB9126874D0 (de)
WO (1) WO1993011756A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0004331A3 (en) * 1997-08-21 2001-09-28 Gerolymatos P N Sa Use of phanquinone for producing pharmaceutical compositions for the treatment of alzheimer's disease and combined pharmaceutical compositions containing it
US6114382A (en) * 1998-11-11 2000-09-05 Moretti; Itagiba G. Methods for treating inflammatory bowel disease
WO2009007991A2 (en) 2007-04-19 2009-01-15 Ipca Laboratories Limited A new process for preparation of atovaquone and novel intermediates thereof
EP2093207A1 (de) * 2008-02-06 2009-08-26 Julius-Maximilians-Universität Würzburg Aus tropischen Lianen isolierte antiinfektiöse und antitumorale Verbindungen
US8283499B2 (en) * 2008-03-07 2012-10-09 Alkem Laboratories Limited Preparation of naphthoquinone compounds using 2,3-dihalonaphthoquinone
CN101781196B (zh) * 2009-01-20 2013-11-27 武汉泰祥通生物技术有限公司 一种制备4-(4-氯苯基)-环己基-1-甲酸的方法
CA2855837A1 (en) * 2011-11-18 2013-05-23 Howard University Methods for treating leishmaniasis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
IE65715B1 (en) * 1988-08-16 1995-11-15 Wellcome Found Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments

Also Published As

Publication number Publication date
ES2144452T3 (es) 2000-06-16
GB9126874D0 (en) 1992-02-19
DE69230790T2 (de) 2000-08-17
US5561164A (en) 1996-10-01
EP0572615B1 (de) 2000-03-15
EP0572615A1 (de) 1993-12-08
DE69230790D1 (de) 2000-04-20
WO1993011756A1 (en) 1993-06-24

Similar Documents

Publication Publication Date Title
DZ1794A1 (fr) Nouvelle formule pharmaceutique.
DE59407237D1 (de) Nitrato-aminosäure-disulfide zur therapie von erkrankungen des herz-kreislauf-systems
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
KR870700599A (ko) 카르복실산유도체, 그의 제조방법, 이화합물을 함유한 약제조성물 및 그의 용도
KR970702291A (ko) 에퀼린의 산 이성질화체로부터 제조된 에퀼린 이중결합 이성질체(Anequilin double bond isomer from the acid isomerization of equilin)
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
ATE205399T1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE69312297D1 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
DE68916651D1 (de) Heilmittel zur behandlung von toxoplasmose.
ATE143946T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
ATE107504T1 (de) Arzneimittel zur behandlung von kryptosporidiose.
ATE223717T1 (de) Topisch anzuwendendes abschäumendes arzneimittel zur behandlung von durch pityrosporum ovale verursachten hauterkrankungen
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
ATE232867T1 (de) Tetronsäurederivate zur behandlung von hiv- und anderen retroviruserkrankungen
ATE357256T1 (de) Arzneimittel zur behandlung von störungen des zirkadianen rhythmus
DE59406844D1 (de) Phosphonobernsteinsäurederivate und ihre verwendung als arzneimittel